Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H ( (HK:2591) ) has provided an announcement.
Guangzhou Innogen Pharmaceutical Group Co., Ltd. has announced a board meeting scheduled for August 29, 2025, to discuss and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the remainder of the year.
More about Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
Guangzhou Innogen Pharmaceutical Group Co., Ltd. is a pharmaceutical company based in China, focusing on the development and production of pharmaceutical products. It operates in the healthcare industry, providing a range of medical solutions.
Average Trading Volume: 9,277,985
For detailed information about 2591 stock, go to TipRanks’ Stock Analysis page.